American Board of Ophthalmology Appoints Three New Directors
Two Mayo-affiliated physicians and one quality measure expert joined the 19-member Board of directors with terms beginning January 1, 2010.
Bala Cynwyd, PA, February 05, 2010 --(PR.com)-- Three new directors of the American Board of Ophthalmology (ABO) began their terms on January 1, 2010:
Keith H. Baratz, MD, is Associate Professor in the Department of Ophthalmology at the Mayo Clinic School of Medicine in Rochester, MN and serves on the editorial board of Archives of Ophthalmology. He is also the former Residency Director and former Director of Research in Mayo’s Department of Ophthalmology. Dr. Baratz’s training includes a medical degree from Duke University School of Medicine in Durham, NC; residency at the Mayo Graduate School of Medicine; and a fellowship at Duke University. His areas of interest include Cornea, External Disease, and Anterior Segment Surgery. Dr. Baratz, who resides in Rochester, MN, was certified by the ABO in 1992 and participates in the Maintenance of Certification (MOC) process.
J. Douglas Cameron, MD, MBA, is Chief of the Division of Ophthalmic Pathology at the Armed Forces Institute of Pathology in Washington, DC and Professor Emeritus of Ophthalmology at the Mayo Clinic School of Medicine. His training includes a medical degree from Northwestern University Medical School in Chicago, IL; residency at Scheie Eye Institute at the University of Pennsylvania in Philadelphia; and fellowships in ophthalmic pathology at Scheie Eye Institute and the Armed Forces Institute of Pathology. Dr. Cameron also holds a master’s degree in Business Administration from the University of St. Thomas in Minneapolis, MN. He resides in Washington, DC. Dr. Cameron was certified by the ABO in 1979 and participates in the Maintenance of Certification (MOC) process.
Paul P. Lee, MD, JD, is Vice-Chairman of the Department of Ophthalmology and Senior Advisor to the Chancellor & Director of Applied Health Systems Research at Duke University School of Medicine in Durham, NC. His training includes a medical degree from the University of Michigan Medical School; residency at Johns Hopkins Hospital in Maryland; and fellowship training in glaucoma at the Massachusetts Eye and Ear Infirmary in Boston. Dr. Lee also holds a degree in law from Columbia University Law School. His awards and recognitions include: Co-Chair of the American Medical Association/American Academy of Ophthalmology (AAO) Consortium Task Force on Quality Measures for Pay for Performance, 2006-2008; AAO Senior Achievement Award, 2005; and the AAO Secretary’s Recognition Award, 2005 and 2007. He currently serves on the Board of Governors of the Association for Research in Vision and Ophthalmology (ARVO) Foundation for Eye Research and is the primary investigator for Duke’s Expanding Quality Care for Glaucoma Through a Provider-Patient Partnership clinical research project. Dr. Lee, who was certified by the ABO in 1991 and participates in the Maintenance of Certification (MOC) process, resides in Chapel Hill, NC.
Directors of the board are selected from a pool of nationally-prominent practicing ophthalmologists. They are tasked with setting strategic goals and executing the overall mission of the ABO. Directors are elected to four-year terms and volunteer significant time to the development of the certification and maintenance of certification examinations and processes. Two non-clinician public directors also serve on the board to represent the voice of the patients and the public.
About the American Board of Ophthalmology:
The ABO is committed to improving the quality of eye and vision care in the United States through rigorous certification and maintenance of certification processes for medical and osteopathic physician specialists (MDs and DOs) that demonstrate: competency in medical knowledge; excellence in professional skills; commitment to high standards in patient care; and evidence of continual learning and improvement. Comprised of 17 practicing ophthalmologists and two public directors, the ABO is an independent, not-for-profit organization and is the nation’s oldest medical specialty board, certifying nearly 27,000 ophthalmologists since 1916. The ABO is one of 24 specialty boards recognized by the American Board of Medical Specialties (ABMS) and the American Medical Association (AMA). To learn more, visit www.abop.org.
Contact:
Meghan Smith • 610.664.1175 x. 24 • msmith@abop.org
###
Keith H. Baratz, MD, is Associate Professor in the Department of Ophthalmology at the Mayo Clinic School of Medicine in Rochester, MN and serves on the editorial board of Archives of Ophthalmology. He is also the former Residency Director and former Director of Research in Mayo’s Department of Ophthalmology. Dr. Baratz’s training includes a medical degree from Duke University School of Medicine in Durham, NC; residency at the Mayo Graduate School of Medicine; and a fellowship at Duke University. His areas of interest include Cornea, External Disease, and Anterior Segment Surgery. Dr. Baratz, who resides in Rochester, MN, was certified by the ABO in 1992 and participates in the Maintenance of Certification (MOC) process.
J. Douglas Cameron, MD, MBA, is Chief of the Division of Ophthalmic Pathology at the Armed Forces Institute of Pathology in Washington, DC and Professor Emeritus of Ophthalmology at the Mayo Clinic School of Medicine. His training includes a medical degree from Northwestern University Medical School in Chicago, IL; residency at Scheie Eye Institute at the University of Pennsylvania in Philadelphia; and fellowships in ophthalmic pathology at Scheie Eye Institute and the Armed Forces Institute of Pathology. Dr. Cameron also holds a master’s degree in Business Administration from the University of St. Thomas in Minneapolis, MN. He resides in Washington, DC. Dr. Cameron was certified by the ABO in 1979 and participates in the Maintenance of Certification (MOC) process.
Paul P. Lee, MD, JD, is Vice-Chairman of the Department of Ophthalmology and Senior Advisor to the Chancellor & Director of Applied Health Systems Research at Duke University School of Medicine in Durham, NC. His training includes a medical degree from the University of Michigan Medical School; residency at Johns Hopkins Hospital in Maryland; and fellowship training in glaucoma at the Massachusetts Eye and Ear Infirmary in Boston. Dr. Lee also holds a degree in law from Columbia University Law School. His awards and recognitions include: Co-Chair of the American Medical Association/American Academy of Ophthalmology (AAO) Consortium Task Force on Quality Measures for Pay for Performance, 2006-2008; AAO Senior Achievement Award, 2005; and the AAO Secretary’s Recognition Award, 2005 and 2007. He currently serves on the Board of Governors of the Association for Research in Vision and Ophthalmology (ARVO) Foundation for Eye Research and is the primary investigator for Duke’s Expanding Quality Care for Glaucoma Through a Provider-Patient Partnership clinical research project. Dr. Lee, who was certified by the ABO in 1991 and participates in the Maintenance of Certification (MOC) process, resides in Chapel Hill, NC.
Directors of the board are selected from a pool of nationally-prominent practicing ophthalmologists. They are tasked with setting strategic goals and executing the overall mission of the ABO. Directors are elected to four-year terms and volunteer significant time to the development of the certification and maintenance of certification examinations and processes. Two non-clinician public directors also serve on the board to represent the voice of the patients and the public.
About the American Board of Ophthalmology:
The ABO is committed to improving the quality of eye and vision care in the United States through rigorous certification and maintenance of certification processes for medical and osteopathic physician specialists (MDs and DOs) that demonstrate: competency in medical knowledge; excellence in professional skills; commitment to high standards in patient care; and evidence of continual learning and improvement. Comprised of 17 practicing ophthalmologists and two public directors, the ABO is an independent, not-for-profit organization and is the nation’s oldest medical specialty board, certifying nearly 27,000 ophthalmologists since 1916. The ABO is one of 24 specialty boards recognized by the American Board of Medical Specialties (ABMS) and the American Medical Association (AMA). To learn more, visit www.abop.org.
Contact:
Meghan Smith • 610.664.1175 x. 24 • msmith@abop.org
###
Contact
American Board of Ophthalmology
Meghan Smith
610-664-1175 ext. 24
www.abop.org
Meghan Smith
610-664-1175 ext. 24
www.abop.org
Contact
Categories